Search

Author/Creator Hunzelmann, N.

31. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies. (20th March 2016)

Authors:
Hunzelmann, N.; Riemekasten, G.; Becker, M.O.; Moinzadeh, P.; Kreuter, A.; Melchers, I.; Mueller‐Ladner, U.; Meier, F.; Worm, M.; Lee, H.; Herrgott, I.; Pfeiffer, C.; Fierlbeck, G.; Henes, J.; Juche, A.; Zeidler, G.; Mensing, H.; Günther, C.; Sárdy, M.; Burkhardt, H.
Journal:
British journal of dermatology
Issue:
Volume 174:Number 6(2016)
Page Start:
1384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

32. THU0244 Additive value of scleroderma health assessment questionnaire (SHAQ) scores over haq disability index values for measuring disability and quality of life in patients with systemic sclerosis. (23rd January 2014)

Authors:
Becker, C.; Huscher, D.; Becker, M.O.; Hunzelmann, N.; Riemekasten, G.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. Whole blood gene expression profiling distinguishes systemic sclerosis‐overlap syndromes from other subsets. (19th February 2020)

Authors:
Moinzadeh, P.; Frommolt, P.; Franitza, M.; Toliat, M. R.; Becker, K.; Nürnberg, P.; Nihtyanova, S. I.; Ahrazoglu, M.; Belz, D.; Hunzelmann, N.; Abraham, D.; Ong, V. H.; Mouthon, L.; Hesselstrand, R.; Denton, C. P.; Krieg, T.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 34:Number 5(2020)
Page Start:
e236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗